Previous Close | 35.94 |
Open | 35.83 |
Bid | 35.42 x 100 |
Ask | 35.63 x 100 |
Day's Range | 35.33 - 36.02 |
52 Week Range | 20.83 - 40.95 |
Volume | |
Avg. Volume | 414,466 |
Market Cap | 1.16B |
Beta (5Y Monthly) | 1.04 |
PE Ratio (TTM) | 27.50 |
EPS (TTM) | 1.29 |
Earnings Date | May 02, 2024 - May 06, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 40.00 |
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
STOUGHTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) (the “Company”), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it has called all $26,350,000 aggregate principal amount of its outstanding 2.625% Convertible Senior Notes Due 2026 (the “Notes”) (CUSIP No. 19459JAA2; ISIN No. US19459JAA25) for redemption on Friday, June 14, 2024 (the “Re
Collegium Pharmaceutical (COLL) closed at $38.79 in the latest trading session, marking a -1.6% move from the prior day.